CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
18.725
0.75%
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 15:30

Mon - Fri: 07:00 - 15:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.090
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.022099 %
Charges from full value of position ($-4.20)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.022099%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.000123 %
Charges from full value of position ($-0.02)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.000123%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency EUR
Margin 5%
Stock exchange Netherlands
Commission on trade 0%

*Information provided by Capital.com

Corbion NV ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 18.585
Open* 18.715
1-Year Change* -37.42%
Day's Range* 18.635 - 18.785
52 wk Range 14.54-37.76
Average Volume (10 days) 68.84K
Average Volume (3 months) 2.46M
Market Cap 1.06B
P/E Ratio 15.89
Shares Outstanding 59.27M
Revenue 1.51B
EPS 1.12
Dividend (Yield %) 3.13725
Beta 1.04
Next Earnings Date Mar 1, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 16, 2024 18.585 0.090 0.49% 18.495 18.745 18.395
Apr 15, 2024 18.805 -0.380 -1.98% 19.185 19.235 18.725
Apr 12, 2024 19.085 -0.550 -2.80% 19.635 19.695 18.955
Apr 11, 2024 19.445 -0.140 -0.71% 19.585 20.030 19.445
Apr 10, 2024 19.665 -0.170 -0.86% 19.835 20.530 19.645
Apr 9, 2024 19.755 0.290 1.49% 19.465 19.795 19.085
Apr 8, 2024 19.635 0.060 0.31% 19.575 19.755 19.475
Apr 5, 2024 19.575 -0.330 -1.66% 19.905 19.905 19.395
Apr 4, 2024 19.835 -0.125 -0.63% 19.960 20.090 19.695
Apr 3, 2024 19.885 -0.020 -0.10% 19.905 19.970 19.545
Apr 2, 2024 19.855 -0.115 -0.58% 19.970 20.150 19.655
Mar 28, 2024 19.905 0.080 0.40% 19.825 20.070 19.495
Mar 27, 2024 19.745 -0.135 -0.68% 19.880 20.010 19.655
Mar 26, 2024 19.950 0.040 0.20% 19.910 20.090 19.775
Mar 25, 2024 20.030 0.705 3.65% 19.325 20.110 18.995
Mar 22, 2024 19.445 -0.040 -0.21% 19.485 19.815 19.375
Mar 21, 2024 19.655 0.380 1.97% 19.275 19.745 19.275
Mar 20, 2024 19.165 0.160 0.84% 19.005 19.335 18.925
Mar 19, 2024 19.215 0.030 0.16% 19.185 19.215 18.885
Mar 18, 2024 19.165 -0.130 -0.67% 19.295 19.435 19.045

Corbion N.V. Events

Time (UTC) Country Event
Friday, April 26, 2024

Time (UTC)

10:59

Country

NL

Event

Q1 2024 Corbion NV Interim Management Statement Release
Q1 2024 Corbion NV Interim Management Statement Release

Forecast

-

Previous

-
Wednesday, May 15, 2024

Time (UTC)

10:59

Country

NL

Event

Corbion NV Annual Shareholders Meeting
Corbion NV Annual Shareholders Meeting

Forecast

-

Previous

-
Friday, May 17, 2024

Time (UTC)

12:00

Country

NL

Event

Corbion NV
Corbion NV

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 1457.9 1070.8 986.5 976.4 897.2
Revenue 1457.9 1070.8 986.5 976.4 897.2
Cost of Revenue, Total 1131.5 801.8 710.6 704.1 639.1
Gross Profit 326.4 269 275.9 272.3 258.1
Total Operating Expense 1347.1 988.8 882.4 915.1 809.3
Selling/General/Admin. Expenses, Total 171.2 154.7 140.2 146.7 129.2
Research & Development 47.2 42.6 37.2 40.6 39.3
Unusual Expense (Income) -2.8 -10.3 -5.6 23.7 1.7
Operating Income 110.8 82 104.1 61.3 87.9
Interest Income (Expense), Net Non-Operating 6 6.2 -15.2 -12.7 -12.7
Other, Net -0.4 -1.7 -1.2 -3.9 -5.4
Net Income Before Taxes 116.4 86.5 87.7 44.7 69.8
Net Income After Taxes 90 78.3 73.1 25.8 54.3
Net Income Before Extra. Items 90 78.3 73.1 25.8 54.3
Net Income 90 78.3 73.1 25.8 54.3
Total Adjustments to Net Income
Income Available to Common Excl. Extra. Items 90 78.3 73.1 25.8 54.3
Income Available to Common Incl. Extra. Items 90 78.3 73.1 25.8 54.3
Dilution Adjustment
Diluted Net Income 90 78.3 73.1 25.8 54.3
Diluted Weighted Average Shares 58.9918 59.4 59.5 59.4 59.3
Diluted EPS Excluding Extraordinary Items 1.52564 1.31818 1.22857 0.43434 0.91568
Dividends per Share - Common Stock Primary Issue 0.476 0.476 0.476 0.476 0.476
Diluted Normalized EPS 1.71888 1.76094 1.1563 1.58923 0.95278
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total revenue 738 770.5 687.4 555.2 515.6
Revenue 738 770.5 687.4 555.2 515.6
Cost of Revenue, Total 565.6 602.4 529.1 427.3 374.5
Gross Profit 172.4 168.1 158.3 127.9 141.1
Total Operating Expense 684.4 718.8 628.3 543.5 445.3
Selling/General/Admin. Expenses, Total 91.5 89.6 81.6 76.8 77.9
Research & Development 24.4 24.1 23.1 26.2 16.4
Unusual Expense (Income) 2.9 2.7 -5.5 13.2 -23.5
Operating Income 53.6 51.7 59.1 11.7 70.3
Interest Income (Expense), Net Non-Operating -14.3 -5.1 10.7 0 4.5
Net Income Before Taxes 39.3 46.6 69.8 11.7 74.8
Net Income After Taxes 28.1 38.2 51.8 10.8 67.5
Net Income Before Extra. Items 28.1 38.2 51.8 10.8 67.5
Net Income 28.1 38.2 51.8 10.8 67.5
Income Available to Common Excl. Extra. Items 28.1 38.2 51.8 10.8 67.5
Income Available to Common Incl. Extra. Items 28.1 38.2 51.8 10.8 67.5
Diluted Net Income 28.1 38.2 51.8 10.8 67.5
Diluted Weighted Average Shares 59.0343 59.0335 58.9501 59.8992 58.9008
Diluted EPS Excluding Extraordinary Items 0.47599 0.64709 0.87871 0.1803 1.14599
Dividends per Share - Common Stock Primary Issue 0 0.476 0 0.476 0
Diluted Normalized EPS 0.53189 0.68944 0.76336 0.47079 0.86756
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 654.3 504.5 385.1 372.5 349.6
Cash and Short Term Investments 58.2 42.2 51.6 45.7 47.1
Cash & Equivalents
Total Receivables, Net 249.2 212.4 143.8 155 144.4
Accounts Receivable - Trade, Net 210.5 163.2 123.7 124.2 119.6
Total Inventory 331.2 230 164.8 163.2 152.7
Prepaid Expenses 12 8.7 6.5 7.1 5.4
Other Current Assets, Total 3.7 11.2 18.4 1.5
Total Assets 1705.4 1341.1 1074.5 1091.1 965.8
Property/Plant/Equipment, Total - Net 729.5 532.9 406.5 433 368.9
Property/Plant/Equipment, Total - Gross 1460.7 1194.8 1027.4 1079.4 927.1
Accumulated Depreciation, Total -731.2 -661.9 -620.9 -646.4 -558.2
Goodwill, Net 83.5 77.7 70.1 80.4 61.3
Intangibles, Net 80.1 80.2 95.6 92.5 77.9
Long Term Investments 27.9 23.2 15.3 16.6 18.7
Note Receivable - Long Term 99.4 94.8 73.7 67.2 62.3
Other Long Term Assets, Total 30.7 27.8 28.2 28.9 27.1
Total Current Liabilities 592.7 321 233.9 347.7 260
Accounts Payable 148.3 128 99.4 94.3 87.8
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 322 84.6 51.4 180.1 116.3
Other Current Liabilities, Total 68.6 64.6 45.7 34.8 55.9
Total Liabilities 1079.7 787 558.5 562 445.6
Total Long Term Debt 437.2 418.6 284.4 168.9 161
Long Term Debt 376 359.1 239.5 113 159.9
Capital Lease Obligations 61.2 59.5 44.9 55.9 1.1
Deferred Income Tax 30 25.4 15.3 13.4 17
Other Liabilities, Total 19.8 22 24.9 32 7.6
Total Equity 625.7 554.1 516 529.1 520.2
Common Stock 14.8 14.8 14.8 14.8 14.8
Additional Paid-In Capital 55.2 55.2 55.2 55.2 55.2
Retained Earnings (Accumulated Deficit) 528.7 467.2 441.6 403.8 414
Other Equity, Total 27 16.9 4.4 55.3 36.2
Total Liabilities & Shareholders’ Equity 1705.4 1341.1 1074.5 1091.1 965.8
Total Common Shares Outstanding 59.0129 58.9503 58.8717 58.8196 58.7646
Total Preferred Shares Outstanding
Cash 58.2 42.2 51.6 45.7 47.1
Accrued Expenses 53.8 43.8 37.4 38.5
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total Current Assets 648 654.3 626.5 504.5 420.5
Cash and Short Term Investments 58.1 58.2 73.7 42.2 38.3
Cash & Equivalents 58.1 58.2 73.7 42.2 38.3
Total Receivables, Net 281.4 264.9 263.2 231.2 203.2
Accounts Receivable - Trade, Net 218.8 210.5 216 163.2 146.9
Total Inventory 308.5 331.2 289.6 230 179
Total Assets 1723.2 1705.4 1596.3 1341.1 1167.6
Property/Plant/Equipment, Total - Net 766.6 729.5 642.3 532.9 433.1
Intangibles, Net 160.5 163.6 164.3 157.9 174.9
Long Term Investments 23.4 27.9 33.4 23.2 22.1
Note Receivable - Long Term 99.8 99.4 96.6 94.8 84.2
Other Long Term Assets, Total 24.9 30.7 33.2 27.8 32.8
Total Current Liabilities 627.3 592.7 503.1 321 273.1
Accounts Payable 129.4 148.3 145.2 128 86.2
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 399.8 322 240 84.6 89.4
Other Current Liabilities, Total 98.1 122.4 117.9 108.4 97.5
Total Liabilities 1102.3 1079.7 999.5 787 606.2
Total Long Term Debt 424.7 437.2 443.7 418.6 291.3
Long Term Debt 368.7 376 379.4 359.1 247.5
Capital Lease Obligations 56 61.2 64.3 59.5 43.8
Deferred Income Tax 28.9 30 30.4 25.4 15.8
Other Liabilities, Total 21.4 19.8 22.3 22 26
Total Equity 620.9 625.7 596.8 554.1 561.4
Common Stock 14.8 14.8 14.8 14.8 14.8
Additional Paid-In Capital 55.2 55.2 55.2 55.2 55.2
Retained Earnings (Accumulated Deficit) 550.9 555.7 526.8 484.1 491.4
Total Liabilities & Shareholders’ Equity 1723.2 1705.4 1596.3 1341.1 1167.6
Total Common Shares Outstanding 59.2731 59.0129 59.0129 58.9503 58.952
Other Current Assets, Total 0 1.1
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 110.8 82 104.1 25.8 54.3
Cash From Operating Activities 39 22.4 109 114.4 99.5
Cash From Operating Activities 76.4 64.1 60.3 61.5 42
Non-Cash Items -3.4 -7.3 -8.7 49.9 32.6
Cash Taxes Paid 18.3 25.5 10.7 4 9.6
Cash Interest Paid 18.1 13 10.8 10 8.7
Changes in Working Capital -144.8 -116.4 -46.7 -22.8 -29.4
Cash From Investing Activities -199.1 -119.4 -76.9 -104.8 -87.6
Capital Expenditures -235.8 -148.7 -88.9 -76.2 -60.1
Other Investing Cash Flow Items, Total 36.7 29.3 12 -28.6 -27.5
Cash From Financing Activities 173.9 85.9 -23.9 -12 -4.3
Total Cash Dividends Paid -33 -33 -33 -32.9 -32.9
Issuance (Retirement) of Stock, Net
Issuance (Retirement) of Debt, Net 221.8 118.9 9.1 20.9 28.6
Net Change in Cash 16 -9.4 5.9 -1.4 9
Foreign Exchange Effects 2.2 1.7 -2.3 1 1.4
Financing Cash Flow Items -14.9
Dec 2022 Jun 2022 Dec 2021 Jun 2021
Net income/Starting Line 110.8 59.1 82 70.3
Cash From Operating Activities 39 18 22.4 15.6
Cash From Operating Activities 76.4 36.3 64.1 30.3
Non-Cash Items -3.4 -7.2 -7.3 -28.3
Cash Taxes Paid 18.3 3.8 25.5 11.5
Cash Interest Paid 18.1 7.3 13 6.2
Changes in Working Capital -144.8 -70.2 -116.4 -56.7
Cash From Investing Activities -199.1 -86.6 -119.4 -29.2
Capital Expenditures -235.8 -112.7 -148.7 -52.8
Other Investing Cash Flow Items, Total 36.7 26.1 29.3 23.6
Cash From Financing Activities 173.9 97.5 85.9 -0.2
Total Cash Dividends Paid -33 -33 -33 -33
Issuance (Retirement) of Debt, Net 221.8 145.4 118.9 32.8
Foreign Exchange Effects 2.2 2.6 1.7 0.5
Net Change in Cash 16 31.5 -9.4 -13.3
Financing Cash Flow Items -14.9 -14.9

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Corbion Company profile

About Corbion NV

Corbion NV is a company based in the Netherlands that is active in the field of biochemical ingredients. The Company's products include lactic acid derivatives, emulsifiers, functional enzyme blends, minerals and vitamins, among others. It operates through two business lines: Ingredient Solutions, divided into business segments Food and Biochemicals, as well as Innovation Platforms. The Food segment develops preservation ingredients and microbial spoilage prevention products for the baking, meat, dairy, confectionery and beverage industries, and the Biochemicals segment produces bio-based chemicals derived from renewable resources such as sugar or starch. The Innovation Platforms segment creates new biotechnology business platforms, such as the poly lactic acid (PLA) bioplastic or its algae ingredients business. The Company operates production sites in the United States, Brazil, Spain, the Netherlands and Thailand, and markets its products through a global network of retail offices.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Corbion NV revenues increased 9% to EUR1.07B. Net income increased 7% to EUR78.3M. Revenues reflect Sustainable Food Solutions segment increase of 7% to EUR584.2M, Lactic Acid and Specialties segment increase of 13% to EUR312.3M, Incubator segment increase from EUR13.4M to EUR30.7M, Asia segment increase of 13% to EUR193.8M, US segment increase of 4% to EUR499.2M.

Equity composition

04/2009, Stock Dividend, 1 new share for every 21 shares held.

Industry: Specialty Chemicals (NEC)

Piet Heinkade 127
AMSTERDAM
NOORD-HOLLAND 1019 GM
NL

Income Statement

  • Annual
  • Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

People also watch

US100

17,746.70 Price
+0.120% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

BTC/USD

63,533.20 Price
+0.710% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.50 Price
+0.870% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Gold

2,391.05 Price
+0.340% 1D Chg, %
Long position overnight fee -0.0192%
Short position overnight fee 0.0109%
Overnight fee time 21:00 (UTC)
Spread 0.40

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading